 Kristen DeSanto
Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acupuncture Therapy | 2 | 2023 | 19 | 1.810 |
Why?
| | Myofascial Pain Syndromes | 2 | 2023 | 14 | 1.800 |
Why?
| | Low Back Pain | 2 | 2023 | 100 | 1.620 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 304 | 1.240 |
Why?
| | Patient Education as Topic | 2 | 2022 | 699 | 1.040 |
Why?
| | Sleep-Wake Transition Disorders | 1 | 2023 | 3 | 0.970 |
Why?
| | Nutrition Therapy | 1 | 2023 | 32 | 0.930 |
Why?
| | Fibromyalgia | 1 | 2023 | 56 | 0.900 |
Why?
| | Naltrexone | 1 | 2023 | 80 | 0.880 |
Why?
| | Postmenopause | 1 | 2023 | 305 | 0.790 |
Why?
| | Hallucinogens | 1 | 2022 | 74 | 0.780 |
Why?
| | Water Sports | 1 | 2020 | 1 | 0.780 |
Why?
| | Analgesics | 2 | 2022 | 159 | 0.760 |
Why?
| | Wound Healing | 1 | 2022 | 270 | 0.740 |
Why?
| | Antipsychotic Agents | 1 | 2022 | 193 | 0.740 |
Why?
| | Behavior Therapy | 1 | 2022 | 237 | 0.730 |
Why?
| | Ganglion Cysts | 1 | 2020 | 10 | 0.720 |
Why?
| | Anti-Asthmatic Agents | 1 | 2023 | 343 | 0.720 |
Why?
| | Carcinoma, Basal Cell | 1 | 2020 | 67 | 0.700 |
Why?
| | Wrist | 1 | 2020 | 51 | 0.700 |
Why?
| | Spironolactone | 1 | 2019 | 34 | 0.690 |
Why?
| | Memory | 1 | 2021 | 230 | 0.680 |
Why?
| | Diuretics | 1 | 2019 | 76 | 0.680 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 301 | 0.660 |
Why?
| | Clostridium Infections | 1 | 2019 | 57 | 0.650 |
Why?
| | Communication | 3 | 2021 | 761 | 0.650 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2174 | 0.640 |
Why?
| | Proton Pump Inhibitors | 1 | 2019 | 98 | 0.640 |
Why?
| | Glycemic Index | 1 | 2018 | 24 | 0.640 |
Why?
| | Viscosupplements | 1 | 2018 | 10 | 0.640 |
Why?
| | Pneumonia, Bacterial | 1 | 2019 | 110 | 0.630 |
Why?
| | Community-Acquired Infections | 1 | 2019 | 143 | 0.610 |
Why?
| | Musculoskeletal System | 1 | 2018 | 55 | 0.600 |
Why?
| | Testosterone | 1 | 2021 | 351 | 0.600 |
Why?
| | Sleep | 1 | 2022 | 660 | 0.580 |
Why?
| | Humans | 43 | 2023 | 118974 | 0.560 |
Why?
| | Gastroesophageal Reflux | 1 | 2019 | 248 | 0.560 |
Why?
| | Chagas Disease | 3 | 2021 | 34 | 0.550 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 197 | 0.550 |
Why?
| | Cannabis | 1 | 2022 | 382 | 0.550 |
Why?
| | Pain Measurement | 3 | 2023 | 469 | 0.520 |
Why?
| | Osteoarthritis, Knee | 1 | 2018 | 223 | 0.500 |
Why?
| | Athletic Injuries | 1 | 2020 | 495 | 0.480 |
Why?
| | Glucocorticoids | 1 | 2018 | 545 | 0.460 |
Why?
| | Skin Neoplasms | 1 | 2020 | 762 | 0.450 |
Why?
| | Health Promotion | 1 | 2018 | 691 | 0.400 |
Why?
| | Hormone Replacement Therapy | 2 | 2023 | 80 | 0.400 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2023 | 1244 | 0.380 |
Why?
| | Asthma | 1 | 2023 | 2158 | 0.370 |
Why?
| | Hypertension | 1 | 2019 | 1203 | 0.370 |
Why?
| | Pain Management | 2 | 2023 | 294 | 0.320 |
Why?
| | Cardiomyopathies | 2 | 2021 | 299 | 0.310 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 1798 | 0.300 |
Why?
| | Advance Care Planning | 2 | 2021 | 191 | 0.290 |
Why?
| | Sepsis | 2 | 2022 | 531 | 0.270 |
Why?
| | Palliative Care | 3 | 2021 | 629 | 0.250 |
Why?
| | Population Groups | 2 | 2021 | 58 | 0.240 |
Why?
| | Muscle Cramp | 1 | 2023 | 8 | 0.240 |
Why?
| | Psychosocial Support Systems | 1 | 2023 | 12 | 0.240 |
Why?
| | Amitriptyline | 1 | 2023 | 21 | 0.230 |
Why?
| | Trigger Points | 1 | 2023 | 14 | 0.230 |
Why?
| | Magnesium | 1 | 2023 | 150 | 0.230 |
Why?
| | Urogenital Abnormalities | 1 | 2023 | 48 | 0.230 |
Why?
| | Transition to Adult Care | 1 | 2023 | 58 | 0.220 |
Why?
| | Stroke | 2 | 2022 | 1047 | 0.220 |
Why?
| | Quetiapine Fumarate | 1 | 2022 | 25 | 0.220 |
Why?
| | Aripiprazole | 1 | 2022 | 18 | 0.220 |
Why?
| | Rectum | 1 | 2023 | 157 | 0.220 |
Why?
| | Leg | 1 | 2023 | 234 | 0.210 |
Why?
| | Administration, Inhalation | 1 | 2023 | 656 | 0.210 |
Why?
| | Aged, 80 and over | 5 | 2021 | 6561 | 0.210 |
Why?
| | Colon | 1 | 2023 | 238 | 0.200 |
Why?
| | Chagas Cardiomyopathy | 1 | 2021 | 21 | 0.200 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1440 | 0.200 |
Why?
| | Benzodiazepines | 1 | 2022 | 122 | 0.200 |
Why?
| | Insulin, Isophane | 1 | 2021 | 16 | 0.200 |
Why?
| | Back Injuries | 1 | 2020 | 5 | 0.190 |
Why?
| | Dermoscopy | 1 | 2020 | 9 | 0.190 |
Why?
| | Drowning | 1 | 2020 | 7 | 0.190 |
Why?
| | Insulin Glargine | 1 | 2021 | 72 | 0.190 |
Why?
| | Facial Injuries | 1 | 2020 | 19 | 0.190 |
Why?
| | Drug Therapy, Combination | 1 | 2023 | 965 | 0.190 |
Why?
| | Sexual and Gender Minorities | 1 | 2023 | 137 | 0.190 |
Why?
| | Torso | 1 | 2020 | 30 | 0.190 |
Why?
| | Transgender Persons | 1 | 2023 | 135 | 0.190 |
Why?
| | Nurse's Role | 1 | 2021 | 102 | 0.190 |
Why?
| | Neck Injuries | 1 | 2020 | 20 | 0.190 |
Why?
| | Health Information Exchange | 1 | 2020 | 12 | 0.190 |
Why?
| | Attitude to Computers | 1 | 2020 | 27 | 0.190 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1171 | 0.180 |
Why?
| | Ambulances | 1 | 2020 | 49 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 521 | 0.180 |
Why?
| | Dietary Supplements | 1 | 2023 | 467 | 0.180 |
Why?
| | Wearable Electronic Devices | 1 | 2020 | 34 | 0.180 |
Why?
| | Pelvis | 1 | 2020 | 92 | 0.180 |
Why?
| | Upper Extremity | 1 | 2020 | 81 | 0.180 |
Why?
| | Bone and Bones | 1 | 2022 | 289 | 0.180 |
Why?
| | Intrauterine Devices | 1 | 2019 | 24 | 0.180 |
Why?
| | Shock, Septic | 1 | 2021 | 187 | 0.170 |
Why?
| | Teaching | 1 | 2021 | 236 | 0.170 |
Why?
| | Colonoscopy | 1 | 2021 | 208 | 0.170 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 146 | 0.170 |
Why?
| | Long-Term Care | 1 | 2019 | 74 | 0.170 |
Why?
| | Volunteers | 1 | 2018 | 30 | 0.160 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2019 | 124 | 0.160 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 164 | 0.160 |
Why?
| | Terminal Care | 1 | 2021 | 187 | 0.160 |
Why?
| | Visual Analog Scale | 1 | 2018 | 31 | 0.160 |
Why?
| | Injections, Intra-Articular | 1 | 2018 | 62 | 0.160 |
Why?
| | Pain | 1 | 2023 | 735 | 0.150 |
Why?
| | Cytokines | 2 | 2022 | 1900 | 0.150 |
Why?
| | Cooperative Behavior | 1 | 2020 | 408 | 0.150 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 360 | 0.150 |
Why?
| | Female | 11 | 2023 | 61565 | 0.150 |
Why?
| | Lower Extremity | 1 | 2020 | 335 | 0.150 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 736 | 0.150 |
Why?
| | Library Services | 1 | 2016 | 8 | 0.150 |
Why?
| | Libraries, Medical | 1 | 2016 | 9 | 0.150 |
Why?
| | Recurrence | 1 | 2020 | 975 | 0.150 |
Why?
| | Cryptococcus | 1 | 2016 | 8 | 0.140 |
Why?
| | Antigens, Fungal | 1 | 2016 | 26 | 0.140 |
Why?
| | Hypoglycemia | 1 | 2021 | 400 | 0.140 |
Why?
| | Prevalence | 2 | 2021 | 2326 | 0.140 |
Why?
| | Meningitis, Cryptococcal | 1 | 2016 | 28 | 0.140 |
Why?
| | Vomiting | 1 | 2016 | 123 | 0.140 |
Why?
| | Hospice Care | 1 | 2019 | 174 | 0.140 |
Why?
| | Skin | 1 | 2020 | 657 | 0.140 |
Why?
| | Perception | 1 | 2018 | 314 | 0.140 |
Why?
| | Survival Analysis | 1 | 2019 | 1267 | 0.130 |
Why?
| | Administration, Oral | 1 | 2018 | 756 | 0.130 |
Why?
| | Acute Disease | 1 | 2018 | 940 | 0.130 |
Why?
| | Prognosis | 2 | 2022 | 3443 | 0.130 |
Why?
| | Emergency Medical Services | 1 | 2022 | 589 | 0.130 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 693 | 0.130 |
Why?
| | Aged | 5 | 2021 | 19657 | 0.130 |
Why?
| | Ultrasonography | 1 | 2019 | 716 | 0.130 |
Why?
| | Ovarian Neoplasms | 1 | 2019 | 420 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1945 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 628 | 0.120 |
Why?
| | Critical Illness | 1 | 2019 | 662 | 0.120 |
Why?
| | Depression | 1 | 2022 | 1132 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2016 | 554 | 0.120 |
Why?
| | Risk Assessment | 2 | 2021 | 3057 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 942 | 0.110 |
Why?
| | Blood Glucose | 1 | 2022 | 1939 | 0.110 |
Why?
| | Risk Factors | 3 | 2021 | 9000 | 0.110 |
Why?
| | United States | 4 | 2021 | 12555 | 0.110 |
Why?
| | Wounds and Injuries | 1 | 2019 | 772 | 0.100 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 1865 | 0.100 |
Why?
| | Adult | 7 | 2022 | 31512 | 0.100 |
Why?
| | Male | 7 | 2021 | 57801 | 0.090 |
Why?
| | Infant | 1 | 2022 | 8293 | 0.080 |
Why?
| | Child | 3 | 2022 | 19129 | 0.080 |
Why?
| | Middle Aged | 5 | 2021 | 27617 | 0.080 |
Why?
| | Lung | 1 | 2019 | 3664 | 0.070 |
Why?
| | Heart Failure | 1 | 2019 | 1969 | 0.070 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 1868 | 0.060 |
Why?
| | Qualitative Research | 2 | 2021 | 953 | 0.060 |
Why?
| | Research Design | 2 | 2021 | 969 | 0.060 |
Why?
| | Incidence | 2 | 2021 | 2424 | 0.060 |
Why?
| | Gender Identity | 1 | 2023 | 102 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2022 | 201 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 164 | 0.050 |
Why?
| | Technology | 1 | 2021 | 83 | 0.050 |
Why?
| | Uncertainty | 1 | 2021 | 101 | 0.050 |
Why?
| | Canada | 1 | 2021 | 340 | 0.050 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 231 | 0.050 |
Why?
| | Late Onset Disorders | 1 | 2019 | 2 | 0.050 |
Why?
| | Vulnerable Populations | 1 | 2021 | 147 | 0.050 |
Why?
| | Triage | 1 | 2022 | 203 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 467 | 0.040 |
Why?
| | Adolescent | 3 | 2023 | 18480 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 388 | 0.040 |
Why?
| | Patient Participation | 1 | 2023 | 369 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2019 | 89 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2023 | 437 | 0.040 |
Why?
| | Stroke Volume | 1 | 2021 | 513 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2021 | 468 | 0.040 |
Why?
| | Health Education | 1 | 2021 | 318 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2020 | 277 | 0.040 |
Why?
| | Point-of-Care Systems | 1 | 2019 | 151 | 0.040 |
Why?
| | Health Information Management | 1 | 2016 | 7 | 0.040 |
Why?
| | Electrocardiography | 1 | 2019 | 556 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2021 | 9342 | 0.040 |
Why?
| | Hospitals, University | 1 | 2016 | 172 | 0.030 |
Why?
| | Kidney | 1 | 2023 | 1353 | 0.030 |
Why?
| | Syndrome | 1 | 2016 | 344 | 0.030 |
Why?
| | Chronic Disease | 1 | 2021 | 1636 | 0.030 |
Why?
| | Health Personnel | 1 | 2021 | 588 | 0.030 |
Why?
| | Young Adult | 2 | 2023 | 10793 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 12978 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2016 | 200 | 0.030 |
Why?
| | Marijuana Abuse | 1 | 2016 | 209 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2513 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1384 | 0.030 |
Why?
| | Inflammation | 1 | 2022 | 2566 | 0.030 |
Why?
| | Biomedical Research | 1 | 2016 | 612 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3171 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4708 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4196 | 0.020 |
Why?
|
|
DeSanto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|